ARQT icon

Arcutis Biotherapeutics
ARQT

Overview Fund Activity

224 hedge funds and large institutions have $1.78B invested in Arcutis Biotherapeutics in 2025 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 87 increasing their positions, 65 reducing their positions, and 45 closing their positions.

Holders
224
Holders Change
-15
Holders Change %
-6.28%
% of All Funds
3.01%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.07%
New
35
Increased
87
Reduced
65
Closed
45
Calls
$8.93M
Puts
$1.25M
Net Calls
+$7.67M
Net Calls Change
-$1.15M

Top Buyers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$31.8M
2
FLSM
2
Frazier Life Sciences Management
California
$138M
3
PHS
3
PFM Health Sciences
California
$12.9M
4
Goldman Sachs
4
Goldman Sachs
New York
$26.5M
5
Bank of America
5
Bank of America
North Carolina
$16.9M

Top Sellers

1
PCH
1
Polar Capital Holdings
United Kingdom
$70.2M
2
PBA
2
Paradigm Biocapital Advisors
New York
$0
3
Invesco
3
Invesco
Georgia
$1.4M
4
CM
4
Cercano Management
Washington
$0
5
Balyasny Asset Management
5
Balyasny Asset Management
Illinois
$0
Name Market Value Shares Shares
Change 		Shares
Change %
SCM
1
Suvretta Capital Management
New York
$162M 11,535,582 +112,604 +1%
Jennison Associates
2
Jennison Associates
New York
$156M 11,109,405 -251,470 -2%
RCMNY
3
Rubric Capital Management (New York)
New York
$151M 10,749,457 -217,215 -2%
FLSM
4
Frazier Life Sciences Management
California
$138M 9,874,511 +1,089,227 +12%
BlackRock
5
BlackRock
New York
$120M 8,532,761 -359,576 -4%
Vanguard Group
6
Vanguard Group
Pennsylvania
$98.8M 7,049,099 +231,021 +3%
PCH
7
Polar Capital Holdings
United Kingdom
$70.2M 5,006,475 -1,700,000 -25%
State Street
8
State Street
Massachusetts
$63.5M 4,526,937 +52,734 +1%
Morgan Stanley
9
Morgan Stanley
New York
$60.5M 4,314,530 +475,989 +12%
GGHC
10
Gilder Gagnon Howe & Co
New York
$58.3M 4,155,763 +59,712 +1%
UBS Group
11
UBS Group
Switzerland
$41.2M 2,937,939 +17,931 +0.6%
Franklin Resources
12
Franklin Resources
California
$38.3M 2,732,777 -28,990 -1%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$36.2M 2,582,567 +35,620 +1%
Janus Henderson Group
14
Janus Henderson Group
United Kingdom
$31.8M 2,263,960 +2,211,360 +4,204%
D.E. Shaw & Co
15
D.E. Shaw & Co
New York
$30.3M 2,163,001 +173,493 +9%
PBPIA
16
Pivotal bioVenture Partners Investment Advisor
California
$29.7M 2,120,508 – –
Ensign Peak Advisors
17
Ensign Peak Advisors
Utah
$28.1M 2,001,439 +13,050 +0.7%
Goldman Sachs
18
Goldman Sachs
New York
$26.5M 1,890,246 +786,833 +71%
American Century Companies
19
American Century Companies
Missouri
$24.2M 1,724,307 +71,815 +4%
Point72 Asset Management
20
Point72 Asset Management
Connecticut
$20.8M 1,485,425 +654,947 +79%
GKIM
21
GW&K Investment Management
Massachusetts
$19.3M 1,378,432 -133,779 -9%
Bank of America
22
Bank of America
North Carolina
$16.9M 1,202,513 +687,562 +134%
DCM
23
Driehaus Capital Management
Illinois
$15.2M 1,085,954 -6,781 -0.6%
CAM
24
Cormorant Asset Management
Massachusetts
$14M 1,000,000 -350,000 -26%
Charles Schwab
25
Charles Schwab
California
$13.5M 965,066 +104,298 +12%
1
2 3 4 5